Effects of Ischemic Preconditioning on Muscle Damage Induced by Excentric Exercise
Healthy

About this trial
This is an interventional prevention trial for Healthy focused on measuring Ischemic Preconditioning, Exercise, Musculoskeletal Pain, Creatine Kinase, Muscle Fatigue, Stress, Physiological
Eligibility Criteria
Inclusion Criteria:
- not having any health condition that contraindicates or prevents EE;
- not having diagnosed diabetes and high blood pressure;
- not having inflammatory, psychiatric, cardiovascular and / or respiratory rheumatic disease;
- not being an alcoholic, using drugs and / or a smoker;
- without a history of knee surgery (for example, meniscal repair and ligament reconstruction) or recent musculoskeletal injury to the lower limbs that may impair performance during tests or interventions (for example, muscle injury, tendinopathy, patellofemoral pain in the lower limbs and / or back pain in the last six months);
- without involvement in any type of training program during the study period;
- not being engaged in the lower limb strength training program during the three months prior to participating in the study;
- not using ergogenic supplements to improve physical performance and / or muscle mass and / or vasoactive drugs;
- not having one or more risk factors predisposing to thromboembolism.
Exclusion Criteria:
- present a health problem that does not allow continuity,
- use medication, electrotherapy or other therapeutic means that may interfere with any result;
- perform unusual or strenuous physical activities during the evaluation period;
- want to leave the study.
Sites / Locations
- Franciele Marques Vanderlei
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Placebo Comparator
No Intervention
IPC-LOP
IPC-40%
IPC-10mmHg:
CONTR
this group will carry out the baseline assessments, perform the ischemic preconditioning using exactly the limb occlusion pressure , then perform post-IPC assessments and start the excentric exercise, and the post-exercise assessments will take place immediately after the end of the EE and will be repeated in 24h, 48h, 72h and 96h.
this group will carry out baseline assessments, perform IPC using 40% more occlusion than LOP, then perform assessments after IPC protocol and start EE, and post exercise assessments will take place immediately after the end of EE and will be repeated in 24h, 48h, 72h and 96h.
this group will perform baseline assessments, perform occlusion-perfusion intervention with 10 mmHg restriction characterizing the placebo, then perform post-IPC assessments and initiate EE, and post-exercise assessments will take place immediately after completion of EE and if will repeat in 24h, 48h, 72h and 96h.
this group will carry out the baseline assessments, immediately after starting the EE, and the post-exercise assessments will happen immediately after the end of the EE and will be repeated in 24h, 48h, 72h and 96h.